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Introduction: Harlequin ichthyosis (HI) is a severe and rare hereditary congenital skin disorder
characterized by excessive dryness, ectropion and eclabion. The association of ichthyosis
with systemic sclerosis has been described in only three children. No patient with general-
ized  morphea (GM) associated with harlequin ichthyosis was described.
Case report: A 4-years and 6-months girl, diagnosed with harlequin ichthyosis based on dif-
fuse  cutaneous thickening, scaling, erythema, ectropion and eclabium since the ﬁrst hours of
birth  was described. She was treated with acitretin (1.0 mg/kg/day) and emollient cream. At
3  years and 9 months, she developed muscle contractures with pain on motion and
limitation in elbows and knees, and diffuse sclerodermic plaques on the abdomen,
back,  suprapubic area and lower limbs. Skin biopsy showed rectiﬁed epidermis and mild
hyperorthokeratosis, reticular dermis with perivascular and periadnexal inﬁltrates of lym-
phocytes and mononuclear cells, and reticular dermis and sweat gland sclerosis surrounded
by  a dense collagen tissue, compatible with scleroderma. The patient fulﬁlled the GM sub-
type  criteria. Methotrexate and prednisone were introduced. At 4 years and 3 months, new
scleroderma lesions occurred and azathioprine was associated with previous therapy, with
no apparent changes after two months.
Discussion: A case of harlequin ichthyosis associated with a GM was reported. The treatment
of  these two conditions is a challenge and requires a multidisciplinary team.
© 2014 Elsevier Editora Ltda. All rights reserved.
Morfeia  generalizada  em  uma  crianc¸a com  ictiose  arlequim,  uma
associac¸ão  raraPalavras-chave:
Ictiose arlequim
r  e  s  u  m  o
Introduc¸ão: Ictiose arlequim é uma doenc¸a cutânea congênita grave, autossômica e rara,
caracterizada por ressecamento excessivo da pele e hiperqueratose. A associac¸ão de ictiose
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Crianc¸as
Morfeia
Esclerodermia
com esclerose sistêmica foi descrita em apenas três crianc¸as. Ainda não foi descrito nenhum
paciente com morfeia generalizada (MG) associada à ictiose arlequim.
Relato de caso: Menina de quatro anos e seis meses de idade com diagnóstico de ictiose
arlequim baseado em espessamento cutâneo difuso, com ﬁssuras, descamac¸ão, eritema e
sangramento da lesão desde as primeiras horas de vida. A paciente foi tratada com acitretina
(1,0  mg/kg/dia) e creme emoliente. Aos três anos e nove meses, desenvolveu contraturas
musculares com dor à movimentac¸ão e limitac¸ão nos cotovelos e joelhos e placas escle-
rodérmicas difusas no abdômen, nas costas, na região suprapúbica e nas extremidades
inferiores. A biópsia de pele mostrou epiderme retiﬁcada e hiperqueratose leve, derme
reticular com linfócitos, inﬁltrado mononuclear perivascular e perianexial e esclerose da
derme  reticular e glândula sudorípara rodeada por um tecido colágeno denso, compatível
com esclerodermia. A paciente preencheu os critérios para o subtipo MG. Metotrexato e
prednisona foram introduzidos. Aos quatro anos e três meses, apresentou novas lesões
esclerodérmicas, associando-se azatioprina à terapêutica anterior, sem resposta após dois
meses.
Discussão: Um caso de ictiose arlequim associada à MG foi descrito. O tratamento dessas
duas condic¸ões é um desaﬁo e requer uma equipe multidisciplinar.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.
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uvenile cutaneous scleroderma is a rare condition in pedi-
tric patients characterized by the involvement of the skin
nd/or subcutaneous tissue.1,2 Generalized morphea (GM) is
n uncommon subtype of localized scleroderma and occurs
n 7% of the patients.2 The association of GM with other cuta-
eous diseases was rarely reported in the literature, especially
ith ichthyosiform diseases.
Of note, ichthyosis comprehends a heterogeneous group of
kin diseases characterized by cutaneous hyperkeratinization
nd may be congenital or acquired.3 Harlequin ichthyosis is a
ongenital form, transmitted in an autosomal recessive mode.
t is the most severe and often fatal form of ichthyosis.4
The association of ichthyosis with scleroderma has been
escribed in only four patients. Three of them had juvenile
ystemic sclerosis, and one of them had localized sclero-
erma. Two of the juvenile systemic sclerosis patients were
ssociated with ichthyotic-appearing lesions,5 and one of
hem with acquired ichthyosis.6 The localized scleroderma
atient was associated with ichthyotic-appearing lesions.5
owever, to our knowledge, no patient with GM scleroderma
ssociated with the harlequim subtype of ichthyosis was
eported. This case is described herein.
ase  report
 4-years and 6-months girl was diagnosed with harlequin
chthyosis at neonatal period, based on diffuse cutaneous
hickening, diffuse plate-like scales, erythema, ﬁssures, bleed-
ng lesions, bilateral ectropion and eclabium since the ﬁrst
ours of life. No history of parental consanguinity and
arlequin ichthyosis were observed. She was a term new-
orn after cesarean delivery. Her birth weight and height
ere 2.650 gm and 43 cm,  respectively. Microcephaly, auricular
inna and nasal abnormalities, alopecia and ﬂexion con-
racture were not evidenced. She was treated with acitretin(1.0 mg/kg/day) and emollient cream. During the ﬁrst 3 months
of life, she had been hospitalized three times due to skin
infections, with improvement after antibiotic treatment. At 3
years, she presented growth retardation with height of 84 cm,
with delayed motor development. Skin biopsy of abdominal
epidermis showing hyperkeratosis paraketatotic, agranulose,
regular epidermal acanthosis and thickening of the dermis
with proliferation of vessels with mild lymphocytic inﬂamma-
tory inﬁltrate and psoriasiform dermatitis (Fig. 1) conﬁrmed
diagnosis of ichthyosis.7 After 9 months, she developed
painful ﬂexion muscle contractures, with pain on motion
and limitation affecting elbows and knees, associated with
generalized ichthyosis lesions, with diffuse pain upon pal-
pation, bilateral ectropion and diffuse scleroderm plaques
without distribution pattern on: abdomen (11 lesions ranged
from 0.5 × 0.5 cm to 3.3 × 3.0 cm), back (13 lesions ranged from
1.0 × 1.0 cm to 2.8 × 3.0 cm), supra-pubic area (3 lesions var-
ied from 0.8 × 1.4 cm to 3.5 × 2.0 cm)  and proximal aspects of
thighs (2 lesions ranged from 1.0 × 1.0 cm to 3.0 × 2.5 cm). Skin
biopsy showed rectiﬁed epidermis and mild hyperorthoker-
atosis, reticular dermis with lymphocyte and mononuclear
cells that inﬁltrate perivascular and periadnexal, and sclero-
sis of reticular dermis and sweat gland surrounded by a dense
collagen tissue, compatible with scleroderma. Hemoglobin,
leukocyte and platelet counts, renal function and urinal-
ysis were normal. The C-reactive protein was 14.4 mg/dL
(reference value <5). The rheumatoid factor, antinuclear anti-
body (ANA), anti-double-stranded DNA (anti-dsDNA), anti-Sm,
anti-RNP, anti-Ro and anti-La antibodies were negative. Tho-
racic computer tomography, echocardiography, barium meal
examination and slit-lamp examination were normal. The
nailfold capillaroscopy was performed without being able to
visualize capillaries due to crusts periungual. Therefore, the
patient fulﬁlled the juvenile localized scleroderma criteria
(GM subtype)8 and methotrexate (0.5 mg/kg/week) and pred-
nisone (1.0 mg/kg/day) were introduced at the age of 3 years
11 months. At 4 years and 1 month, methotrexate dosage was
increased to 1.0 mg/kg/week. At 4 years and 3 months, she pre-
sented generalized ichthyosis lesions with new scleroderma
84  r e v b r a s r e u m a t o l .
Fig. 1 – Hyperkeratosis paraketatotic, agranulose, regular
epidermal acanthosis and thickening of the dermis with
proliferation of vessels with mild lymphocytic
inﬂammatory inﬁltrate and psoriasiform dermatitis.
lesions in abdomen (Fig. 2), lower limbs, back and supra-pubic
areas and azathioprine (3.0 mg/kg/day) was introduced along
with prednisone and methotrexate with no improvement after
two months of therapy. Topical corticosteroid was not used.
At present, her follow-up is composed of a multidisciplinary
team with a rheumatologist, dermatologist, ophthalmologist,
geneticist, physiotherapist and occupational therapist.
Fig. 2 – Diffuse cutaneous thickening, cracking, scaling,
erythema, bleeding and ichthyosiform lesions, and diffuse
scleroderm plaques (arrow) on the abdomen. 2 0 1 6;5 6(1):82–85
Discussion
To our knowledge, we describe herein the ﬁrst case of
harlequin ichthyosis associated to GM diagnosis. This congen-
ital disease occurred previously to the scleroderma diagnosis,
not in agreement with the rare cases of acquired ichthyosis
and scleroderma reported in the literature.5,6
According to the new classiﬁcation criteria, localized scle-
roderma has four different subtypes: plaque morphea, GM,
linear scleroderma and deep morphea.8–10 The GM is deﬁned
by the presence of four or more  plaques, with individual
plaques greater than 3 cm and involving at least two out of
seven anatomic sites,2 as evidenced in our patient that pre-
sented lesions occurring in upper and lower limbs, and trunk.
Furthermore, ichthyosis is composed of cutaneous kera-
tinization diseases that can be inherited or acquired.3
Congenital ichthyosis is often associated with a variety of typi-
cal neonatal phenotypes with scaling and erythema. The main
subtypes are congenital ichthyosiform erythroderma, lamellar
and harlequin ichthyosis, including overlapping phenotypes.
The mild subtype is congenital ichthyosiform erythroderma
with ﬁne and white scaling, and different degrees of erythema.
Coarse and brown/dark scaling are observed in lamellar
ichthyosis, generally with collodion membrane and ectropion.
The harlequin ichthyosis is a more  severe subtype associated
with very scaling erythroderma, collodion membrane and pro-
nounced ectropion.5,11 Of note, a collodion baby is deﬁned by
erythroderma, shiny and tight skin, like parchment, covering
the entire body at birth. It is an initial presentation of sev-
eral genetic conditions, including congenital ichthyosis,12 as
observed in our case.
The disease course is generally severe with multiple joint
contractures.13,14 Our patient presented contractures mainly
in elbows and knees, possibly due to association with GM.
One limitation of the present case was the absence of
electronic microscopy in the skin biopsy and genetic evalua-
tions, since this is an autosomal recessive congenital disease.5
ABCA12 mutation analysis showed that 52% of survivors had
heterozygous mutations, and all deaths were associated with
homozygous mutations, while missense mutations are usu-
ally related with milder phenotypes.5,15,16 The association
between harlequin ichthyosis and scleroderma, an autoim-
mune disease, is probably coincidental.
Of note, acquired ichthyosis with systemic sclerosis has
been described in four patients after this autoimmune
diagnosis,6,7 however the rare subtype of harlequin had
not been previously reported. Other associations between
harlequin ichthyosis and autoimmune chronic disorders have
been rarely described without a clear relationship with patho-
genesis of autoimmunity, such as hypothyroidism,13 celiac
disease17 and juvenile idiopathic arthritis.13,14
The ichthyosis treatment is based on the severity of the dis-
ease and included topical formulations and oral retinoids,18
as indicated in our patient with unsatisfactory response.
Moreover, the cutaneous juvenile scleroderma includes phar-
macological (glucocorticosteroids and methotrexate) and
non-pharmacological (physical exercises and early physio-
therapy) therapies.19 Azathioprine may also be administered
in refractory cases,20 as used in the present case. The difﬁculty
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f the treatment concomitantly of these two severe and rare
onditions should have contributed to the poor response ther-
py in our case.
The outcome of harlequin ichthyosis is generally related
o stillbirth or ﬁrst weeks of life death due to prematurity,
enal failure, respiratory insufﬁciency and infection.21 To our
nowledge, only eight cases with isolated harlequin ichthyosis
r associated with juvenile rheumatoid arthritis survived the
eonatal period, with a median of current age of 4 years
ranged from 6 months to 14 years).13
In conclusion, we  reported the ﬁrst case of harlequin
chthyosis associated with a rare type of juvenile scleroderma.
he treatment of these two simultaneous illnesses is very
hallenging indeed and requires a multidisciplinary team.
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